Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ALEX Stock Summary
Top 10 Correlated ETFs
ALEX
In the News
New Strong Sell Stocks for March 11th
ALEX, CSCO and NXST have been added to the Zacks Rank #5 (Strong Sell) List on March 11, 2024.
Alexander & Baldwin, Inc. (ALEX) Q4 2023 Earnings Call Transcript
Alexander & Baldwin, Inc. (ALEX) Q4 2023 Earnings Call Transcript
Alexander & Baldwin Holdings, Inc. (ALEX) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Alexander & Baldwin Holdings, Inc. (ALEX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alexander & Baldwin Holdings, Inc. (ALEX) Q4 FFO and Revenues Surpass Estimates
Alexander & Baldwin Holdings, Inc. (ALEX) came out with quarterly funds from operations (FFO) of $0.29 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to FFO of $0.31 per share a year ago.
New Strong Sell Stocks for January 5th
ALEX, CHRD and FIHL have been added to the Zacks Rank #5 (Strong Sell) List on January 5, 2024.
New Strong Sell Stocks for November 21st
ALEX, BASFY and FVCB have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2023.
Alexander & Baldwin, Inc. (ALEX) Q3 2023 Earnings Call Transcript
Alexander & Baldwin, Inc. (NYSE:ALEX ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Steve Swett - Investor Relations Lance Parker - Chief Executive Officer Clayton Chun - Chief Financial Officer Kit Millan - Senior Vice President-Asset Management Conference Call Participants Connor Mitchell - Piper Sandler Operator Hello, and welcome to the Alexander & Baldwin Third Quarter 2023 earnings conference call. All participants will be in listen only mode.
Alexander & Baldwin: Multiple Catalysts
Alexander & Baldwin's current P/FFO valuation multiple is way below its historical average. Alexander & Baldwin's potential catalysts include a faster pace of share repurchases, initiatives to maximize the value of portfolio assets, and earnings beats for Q4 2023 and 2024. I retain my Buy rating for ALEX in consideration of both valuations and catalysts.
Alexander & Baldwin Announces Third Quarter 2023 Earnings Release and Conference Call Date
HONOLULU , Oct. 13, 2023 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) ("A&B" or "Company"), a Hawai'i-based company focused on owning, operating, and developing high-quality commercial real estate in Hawai'i, will report results for the third quarter 2023 after the market closes on Thursday, November 2, 2023. In connection with this announcement, A&B will host a conference call on Thursday, November 2, 2023, at 5:00 p.m.
Down -6.53% in 4 Weeks, Here's Why Alexander & Baldwin Holdings, Inc. (ALEX) Looks Ripe for a Turnaround
Alexander & Baldwin Holdings, Inc. (ALEX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ALEX Financial details
ALEX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.08 | 4.22 | 5.23 | 3.17 | 2.88 | |
Net income per share | -0.52 | 0.08 | 0.24 | -0.68 | 0.41 | |
Operating cash flow per share | 2.2 | 0.87 | 1.71 | 0.47 | 0.92 | |
Free cash flow per share | -1.36 | 0.53 | 0.98 | 0.17 | 0.49 | |
Cash per share | 0.21 | 0.79 | 0.97 | 0.53 | 0.19 | |
Book value per share | 15.71 | 15.16 | 14.71 | 14.27 | 13.82 | |
Tangible book value per share | 14.5 | 14.16 | 13.98 | 13.66 | 13.2 | |
Share holders equity per share | 15.71 | 15.16 | 14.71 | 14.27 | 13.82 | |
Interest debt per share | 10.5 | 9.25 | 8.39 | 15.2 | 6.67 | |
Market cap | 1.5B | 1.24B | 1.82B | 1.36B | 1.38B | |
Enterprise value | 2.19B | 1.89B | 2.3B | 1.8B | 1.83B | |
P/E ratio | -40.69 | 221.81 | 105.76 | -27.47 | 46.34 | |
Price to sales ratio | 3.45 | 4.07 | 4.8 | 5.9 | 6.61 | |
POCF ratio | 9.53 | 19.68 | 14.65 | 39.99 | 20.58 | |
PFCF ratio | -15.4 | 32.69 | 25.73 | 110.55 | 38.46 | |
P/B Ratio | 1.33 | 1.13 | 1.71 | 1.31 | 1.38 | |
PTB ratio | 1.33 | 1.13 | 1.71 | 1.31 | 1.38 | |
EV to sales | 5.03 | 6.19 | 6.07 | 7.82 | 8.77 | |
Enterprise value over EBITDA | 49.01 | 22.19 | 20.45 | 15.27 | 13 | |
EV to operating cash flow | 13.9 | 29.96 | 18.53 | 53.05 | 27.31 | |
EV to free cash flow | -22.47 | 49.75 | 32.55 | 146.63 | 51.04 | |
Earnings yield | -0.02 | 0 | 0.01 | -0.04 | 0.02 | |
Free cash flow yield | -0.06 | 0.03 | 0.04 | 0.01 | 0.03 | |
Debt to equity | 0.64 | 0.58 | 0.55 | 0.92 | 0.46 | |
Debt to assets | 0.35 | 0.31 | 0.31 | 0.53 | 0.28 | |
Net debt to EBITDA | 15.42 | 7.61 | 4.29 | 3.76 | 3.2 | |
Current ratio | 1.48 | 1.81 | 1.18 | 1.03 | 0.33 | |
Interest coverage | -0.18 | 0.98 | 2.36 | 0.54 | 5.15 | |
Income quality | -4.1 | 12.13 | 3.47 | -0.69 | 1.79 | |
Dividend Yield | 0.03 | 0.01 | 0.03 | 0.04 | 0.05 | |
Payout ratio | -1.36 | 2.46 | 2.71 | -1.17 | 2.16 | |
Sales general and administrative to revenue | 0.05 | 0.16 | 0.14 | 0.16 | 0.17 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.04 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -1.62 | -0.4 | -0.43 | -0.64 | -0.46 | |
Capex to revenue | -0.59 | -0.08 | -0.14 | -0.09 | -0.15 | |
Capex to depreciation | -5.05 | -0.47 | -1.06 | -0.57 | -0.86 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | |
Graham number | 13.49 | 5.14 | 8.86 | 14.79 | 11.3 | |
ROIC | 0 | 0.02 | 0.02 | 0.03 | 0.05 | |
Return on tangible assets | -0.02 | 0 | 0.01 | -0.03 | 0.02 | |
Graham Net | -12.15 | -11.48 | -9.6 | -8.69 | -8.38 | |
Working capital | 72.3M | 102.8M | 36.5M | 6.7M | -112.3M | |
Tangible asset value | 1.11B | 1.02B | 1.01B | 991.4M | 958M | |
Net current asset value | -733M | -710.8M | -571.9M | -480.5M | -587.4M | |
Invested capital | 0.64 | 0.58 | 0.55 | 0.92 | 0.46 | |
Average receivables | 87.6M | 68.55M | 49.1M | 26.75M | 20.55M | |
Average payables | 26M | 13.8M | 9.85M | 7.2M | 5.15M | |
Average inventory | 23.6M | 19.55M | 19.35M | 74.05M | 63.9M | |
Days sales outstanding | 66.59 | 68.98 | 38.97 | 20.59 | 49.1 | |
Days payables outstanding | 15.57 | 15.32 | 14.22 | 16.64 | 30.11 | |
Days of inventory on hand | 18.1 | 28.76 | 29.16 | 472.61 | 0 | |
Receivables turnover | 5.48 | 5.29 | 9.37 | 17.73 | 7.43 | |
Payables turnover | 23.45 | 23.83 | 25.67 | 21.93 | 12.12 | |
Inventory turnover | 20.16 | 12.69 | 12.52 | 0.77 | 0 | |
ROE | -0.03 | 0.01 | 0.02 | -0.05 | 0.03 | |
Capex per share | -3.56 | -0.35 | -0.74 | -0.3 | -0.43 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.98 | 0.7 | 0.73 | 0.72 | 0.73 | |
Net income per share | -0.99 | 0.26 | 0.18 | 0.2 | -0.05 | |
Operating cash flow per share | 0.34 | 0.08 | 0.05 | 0.47 | 0.32 | |
Free cash flow per share | 0.26 | 0.03 | -0.14 | 0.39 | 0.21 | |
Cash per share | 0.54 | 0.21 | 0.18 | 0.29 | 0.19 | |
Book value per share | 14.29 | 13.96 | 14.1 | 14.17 | 13.85 | |
Tangible book value per share | 13.67 | 13.37 | -0.55 | 13.66 | 13.23 | |
Share holders equity per share | 14.29 | 13.96 | 14.1 | 14.17 | 13.85 | |
Interest debt per share | 14.52 | 8.78 | -0.93 | 7.19 | 6.48 | |
Market cap | 1.36B | 1.37B | 1.35B | 1.21B | 1.38B | |
Enterprise value | 1.8B | 1.84B | 1.34B | 1.71B | 1.83B | |
P/E ratio | -4.73 | 18.43 | 25.17 | 20.8 | -98.36 | |
Price to sales ratio | 19.18 | 27.2 | 25.4 | 23.14 | 26.03 | |
POCF ratio | 54.32 | 249.27 | 364.57 | 35.31 | 58.6 | |
PFCF ratio | 71.47 | 548.39 | -134.89 | 43.38 | 89.42 | |
P/B Ratio | 1.31 | 1.35 | 1.32 | 1.18 | 1.37 | |
PTB ratio | 1.31 | 1.35 | 1.32 | 1.18 | 1.37 | |
EV to sales | 25.45 | 36.56 | 25.29 | 32.62 | 34.56 | |
Enterprise value over EBITDA | 56.66 | 56.69 | 44.76 | 62.5 | 57.86 | |
EV to operating cash flow | 72.07 | 334.98 | 362.89 | 49.78 | 77.81 | |
EV to free cash flow | 94.83 | 736.95 | -134.27 | 61.16 | 118.73 | |
Earnings yield | -0.05 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | 0.01 | 0 | -0.01 | 0.02 | 0.01 | |
Debt to equity | 0.92 | 0.62 | -0.07 | 0.5 | 0.46 | |
Debt to assets | 0.53 | 0.36 | -0.04 | 0.29 | 0.28 | |
Net debt to EBITDA | 13.96 | 14.5 | -0.21 | 18.17 | 14.28 | |
Current ratio | 1.03 | 2.79 | 0.26 | 1.73 | 0.33 | |
Interest coverage | 0.27 | 4.66 | 4.14 | 2.79 | 5.09 | |
Income quality | -0.35 | 1.04 | 0.25 | 2.16 | 2.87 | |
Dividend Yield | 0 | 0.02 | 0.01 | 0.01 | 0 | |
Payout ratio | 0 | 1.72 | 1.21 | 1.1 | -0.03 | |
Sales general and administrative to revenue | 0.59 | 0.13 | 0.19 | 0.14 | 0.15 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.24 | -0.55 | -3.7 | -0.19 | -0.34 | |
Capex to revenue | -0.08 | -0.06 | -0.26 | -0.12 | -0.15 | |
Capex to depreciation | -1.22 | -0.33 | -1.51 | -0.69 | -0.93 | |
Stock based compensation to revenue | 0 | 0.03 | 0.05 | 0.02 | 0.02 | |
Graham number | 17.83 | 8.98 | 7.65 | 8.01 | 3.88 | |
ROIC | 0.01 | 0.01 | 0.03 | 0.01 | -0.01 | |
Return on tangible assets | -0.04 | 0.01 | 0.01 | 0.01 | 0 | |
Graham Net | -8.71 | -8.95 | -24.91 | -8.89 | -8.4 | |
Working capital | 6.7M | 155M | -57.3M | 114.4M | -112.3M | |
Tangible asset value | 991.4M | 969.5M | -39.7M | 991.5M | 958M | |
Net current asset value | -480.5M | -494.5M | -1.77B | -477.2M | -587.4M | |
Invested capital | 0.92 | 0.62 | -0.07 | 0.5 | 0.46 | |
Average receivables | 27.5M | 12.6M | 11.85M | 11.2M | 19.5M | |
Average payables | 11.5M | 4.7M | 5.05M | 5.65M | 5.95M | |
Average inventory | 78.95M | 126.95M | 17.45M | 26.85M | 72.45M | |
Days sales outstanding | 16.53 | 21.79 | 19.49 | 18.69 | 47.81 | |
Days payables outstanding | 3.85 | 21.2 | 20.62 | 23.36 | 23.51 | |
Days of inventory on hand | 109.44 | 545.63 | -361.59 | 554.94 | 0 | |
Receivables turnover | 5.45 | 4.13 | 4.62 | 4.82 | 1.88 | |
Payables turnover | 23.36 | 4.24 | 4.37 | 3.85 | 3.83 | |
Inventory turnover | 0.82 | 0.16 | -0.25 | 0.16 | 0 | |
ROE | -0.07 | 0.02 | 0.01 | 0.01 | 0 | |
Capex per share | -0.08 | -0.04 | -0.19 | -0.09 | -0.11 |
ALEX Frequently Asked Questions
What is Alexander & Baldwin, Inc. stock symbol ?
Alexander & Baldwin, Inc. is a US stock , located in Honolulu of Hi and trading under the symbol ALEX
Is Alexander & Baldwin, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $22. The lowest prediction is $22 and the highest is $22
What is ALEX stock prediction ?
What is Alexander & Baldwin, Inc. stock quote today ?
Alexander & Baldwin, Inc. stock price is $16.43 today.
Is Alexander & Baldwin, Inc. stock public?
Yes, Alexander & Baldwin, Inc. is a publicly traded company.